Compare TAK & BIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAK | BIDU |
|---|---|---|
| Founded | 1781 | 2000 |
| Country | Japan | China |
| Employees | 47455 | 33500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.4B | 43.1B |
| IPO Year | N/A | N/A |
| Metric | TAK | BIDU |
|---|---|---|
| Price | $15.95 | $116.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $154.38 |
| AVG Volume (30 Days) | ★ 3.0M | 2.4M |
| Earning Date | 05-13-2026 | 05-18-2026 |
| Dividend Yield | ★ 3.24% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.16 | $5.11 |
| Revenue Next Year | $1.22 | $7.44 |
| P/E Ratio | ★ $41.25 | $42.45 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.99 | $83.40 |
| 52 Week High | $18.90 | $165.30 |
| Indicator | TAK | BIDU |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 37.31 |
| Support Level | $15.63 | $107.10 |
| Resistance Level | $16.48 | $130.66 |
| Average True Range (ATR) | 0.21 | 4.97 |
| MACD | 0.07 | -2.27 |
| Stochastic Oscillator | 77.27 | 13.38 |
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
Most of Baidu's revenue comes from Baidu core, with the rest coming from video-streaming subsidiary iQiyi. The firm's main businesses include online marketing services from its search engine, AI cloud infrastructure, AI applications, AI marketing, and autonomous driving.